Alarming new data suggest that the global scope of multidrug-resistant tuberculosis (MDR-TB) is much more vast than previously estimated, requiring a concerted international effort to combat this deadlier form of the disease, the medical humanitarian organization Médecins Sans Frontières (MSF) announced today.

Tuberculosis on the retreat in Europe but concerns about drug-resistant TB and treatment failure remain.

The HIV/TB study showes that 30% of people living with HIV in the Eastern European region also suffering from TB, die within 12 months after the diagnosis, and most of them die from TB. The development of MDR-TB is a huge problem not only for the people living with HIV, but also for the rest of the population in the region and in the rest of Europe.

The Stop TB Partnership Working Group on New TB Vaccines presents the Tuberculosis Vaccine Candidates 2011, as an update of the 2009 Pipeline.

On March 8, and across the world the International Women's Day is being commemorated. Coincidentally, March is the global tuberculosis (TB) awareness month. The disease, which is caused by a mycrobatrium, has a major impact on women's sexual reproductive health and that of their children.

After seven years of research, the world's largest study of preventative tuberculosis (TB) therapy has found that untargeted, community-wide distribution of TB prevention drugs did not improve TB control on South African gold mines.

A renewed call for cheap tests that can rapidly identify resistant forms of the disease.

According to the District Health Barometer, TB and HIV are still the main causes of death. But the Barometer reveals that some districts have shown great improvements in tackling these diseases.

Updated WHO guidance launched today scales up effective public health interventions to reduce TB deaths for people living with HIV.

Dudley Lee's case reveals how overcrowding and a struggling court system are fuelling a TB epidemic.